Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0000950129-03-005507
Filing Date
2003-11-12
Accepted
2003-11-12 06:11:01
Documents
5
Period of Report
2003-06-30

Document Format Files

Seq Description Document Type Size
1 ISOLAGEN, INC. - DATED 6/30/2003 h10435e10vqza.txt 10-Q/A 109645
3 CERTIFICATION OF CEO PURSUANT TO SECTION 302 h10435exv31w1.txt EX-31.1 2794
4 CERTIFICATION OF CFO PURSUANT TO SECTION 302 h10435exv31w2.txt EX-31.2 2784
5 CERTIFICATION OF CEO PURSUANT TO SECTION 906 h10435exv32w1.txt EX-32.1 1490
6 CERTIFICATION OF CFO PURSUANT TO SECTION 906 h10435exv32w2.txt EX-32.2 1484
  Complete submission text file 0000950129-03-005507.txt   120638
Mailing Address 2500 WILCREST 5TH FLOOR HOUSTON TX 77042
Business Address 2500 WILCREST 5TH FLOOR HOUSTON TX 77042 713-780-4754
ISOLAGEN INC (Filer) CIK: 0000357097 (see all company filings)

EIN.: 870458888 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 001-31564 | Film No.: 03990219
SIC: 2834 Pharmaceutical Preparations